Are you a new member? Sign up now
Login area
| Sign up
close
STABURIC - 120mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M04AA03 | G | Febuxostat - 120mg | 10680 | 135520/1 | STABURIC | 120mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 1,420,889 L.L | 23.08 | B | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M04AA03 | B | Febuxostat - 120mg | 9602 | 107818/1 | ADENURIC | 120mg | 28 | Tablet, film coated | Oral | Droguerie de l'Union | Fully manufactured by Algorithm S.A.L. under license from Teijin Pharma Ltd Japan | Lebanon | 2,184,704 L.L | 23.08 | B | 2/5/2024 | 0 | ||
| M04AA03 | G | Febuxostat - 120mg | 10691 | 58320/1 | FEBUXOSTAT ARROW | 120mg | 28 | Tablet, film coated | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 1,084,481 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
| M04AA03 | G | Febuxostat - 120mg | 10098 | 161519/1 | FEBUXOSTAT BIOGARAN | 120mg | 28 | Tablet, film coated | Oral | Commercial and Trading Ressources SAL (CTR) | Bluepharma Industria Farmaceutica SA | Portugal | 1,402,972 L.L | 23.08 | A2 | Laboratoires Biogaran | France | 2/5/2024 | 0 |
| M04AA03 | G | Febuxostat - 120mg | 10924 | 92820/1 | OXUBAT 120 | 120mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Manufactured by MSN Laboratories Private Ltd, India for Benta SAL | Lebanon | 1,549,002 L.L | 23.08 | B | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024